Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic ResponseElisa C. Toffoli, Tanja D. de Gruijl, Henk M.W. Verheul et al.|Cancers|2021Cited by 41
Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15.Abdolkarim Sheikhi, Mohammad Hojjat‐Farsangi, Abdollah Jafarzadeh et al.|PubMed|2016Cited by 27
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor ReceptorElisa C. Toffoli, Abdolkarim Sheikhi, Roeland Lameris et al.|Cancers|2021Cited by 22
An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike proteinAbdolkarim Sheikhi, Mohammad Hojjat‐Farsangi|Human Vaccines & Immunotherapeutics|2020Cited by 15
634 Production and testing of a novel bispecific nanobody construct targeting NK cells and EGFR expressing malignanciesElisa C. Toffoli, Abdolkarim Sheikhi, Roeland Lameris et al.|Regular and Young Investigator Award Abstracts|2020Cited by 1